Literature DB >> 6707138

High-performance liquid chromatographic analysis of isoxicam in human plasma and urine.

A C Daftsios, E L Johnson, F J Keeley, C Gryczko, V Rawski.   

Abstract

A sensitive, selective, and rapid high-performance liquid chromatographic procedure was developed for the determination of isoxicam in human plasma and urine. Acidified plasma or urine were extracted with toluene. Portions of the organic extract were evaporated to dryness, the residue dissolved in tetrahydrofuran (plasma) or acetonitrile (urine) and chromatographed on a mu Bondapak C18 column preceded by a 4-5 cm X 2 mm I.D. column packed with Corasil C18. Quantitation was obtained by UV spectrometry at 320 nm. Linearity in plasma ranged from 0.2 to 10 micrograms/ml. Recoveries from plasma samples seeded with 1.8, 4 and 8 micrograms/ml isoxicam were 1.86 +/- 0.077, 4.10 +/- 0.107 and 8.43 +/- 0.154 micrograms/ml with relative standard deviations of 3.3%, 2.5% and 5.4%, respectively. The linearity in urine ranged from 0.125 to 2 micrograms/ml. The precision of the method was 3.3-9.0% relative standard deviation over the linear range.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707138     DOI: 10.1016/s0378-4347(00)83322-8

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Pharmacokinetics of isoxicam in hepatic disease.

Authors:  N Ferry; G Cuisinaud; D Ouzan; C Trepo; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.

Authors:  L Patoia; G Clausi; F Farroni; P Alberti; P Fugiani; L Bufalino
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.